Pentosan polysulfate 100 MG Oral Capsule [Elmiron] — RxCUI 211140
RxNorm drug concept · Semantic branded drug
RxCUI 211140
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI211140
Official namePentosan polysulfate 100 MG Oral Capsule [Elmiron]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asElmiron 100 MG Oral Capsule
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)9,962 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pentosan Polysulfate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It relieves bladder pain or discomfort from interstitial cystitis. This is a long-term bladder condition. It is taken as a capsule by mouth.
- Take one capsule three times a day with water. Take it at least 1 hour before a meal or 2 hours after. Follow your prescriber's directions.
- Your prescriber will check your progress after about 3 months. If you are improving and not having limiting side effects, it may continue another 3 months. The label says the value...
- Yes. Long-term use has been linked to changes in the retina that may cause trouble reading, slow adjustment to dim light, or blurry vision. These changes may be irreversible. Get r...
🕸️ Concept Web — How Pentosan polysulfate 100 MG Oral Capsule [Elmiro... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Pentosan polysulfate 100 MG Oral Capsule [Elmiron]
RxCUI 211140 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Pentosan polysulfate
155046IN
-
Pentosan polysulfate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Elmiron
155043BN
-
Elmiron
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pentosan polysulfate Oral Capsule
373284SCDF -
Pentosan polysulfate Oral Product
1165405SCDG -
Pentosan polysulfate Pill
1165406SCDG -
Pentosan polysulfate Oral Capsule [Elmiron]
366513SBDF -
Elmiron Oral Product
1174622SBDG -
Elmiron Pill
1174623SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Pentosan polysulfate Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pentosan polysulfate 100 MG Oral Capsule
199498SCD -
Pentosan polysulfate 100 MG
330108SCDC -
Pentosan polysulfate 100 MG [Elmiron]
571599SBDC
-
Pentosan polysulfate 100 MG Oral Capsule
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pentosan polysulfate 100 MG Oral Capsule
SCD · 199498 -
Pentosan polysulfate 100 MG
SCDC · 330108 -
Pentosan polysulfate Oral Capsule
SCDF · 373284 -
Pentosan polysulfate Oral Product
SCDG · 1165405 -
Pentosan polysulfate Pill
SCDG · 1165406
Brand-Name Concepts
-
Pentosan polysulfate 100 MG [Elmiron]
SBDC · 571599 -
Pentosan polysulfate Oral Capsule [Elmiron]
SBDF · 366513 -
Elmiron Oral Product
SBDG · 1174622 -
Elmiron Pill
SBDG · 1174623 -
Elmiron
BN · 155043
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 211140 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50458-0098-01 | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (50458-098-01) | ELMIRON | Janssen Pharmaceuticals, Inc. | 1996-09-26 |
Observed labelers:
Janssen Pharmaceuticals, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$12.0956
Range $12.0956–$12.0956
· middle 50% $12.0956–$12.0956
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.